{
    "2019-02-06": [
        [
            {
                "time": "2019-02-06",
                "original_text": "At least four pharma CEOs to testify at Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "pharma",
                        "CEOs",
                        "testify",
                        "Senate",
                        "drug pricing"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Sightbox CEO on life after acquisition and growth under J&J",
                "features": {
                    "keywords": [
                        "Sightbox",
                        "CEO",
                        "acquisition",
                        "growth",
                        "J&J"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying",
                "features": {
                    "keywords": [
                        "Congress",
                        "drugmakers",
                        "testify",
                        "hostile",
                        "hearing",
                        "drug prices"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "NVLN",
                        "AGLE",
                        "VNDA",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Pfizer CEO Bourla plans to testify at Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "Bourla",
                        "testify",
                        "Senate",
                        "drug pricing"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Winners & Losers from Trump's State of the Union Address",
                "features": {
                    "keywords": [
                        "Winners",
                        "Losers",
                        "Trump",
                        "State of the Union"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}